Home » RECALLS, LAWSUITS MAKE MEDICAL DEVICE MERGER HAIRY
RECALLS, LAWSUITS MAKE MEDICAL DEVICE MERGER HAIRY
Boston Scientific triumphed last month in the fierce merger war for Guidant,
outlasting Johnson & Johnson with a $27 billion offer. But now Boston Scientific
and Guidant, leading heart-device makers in the growing $250 billion market
for medical devices and supplies, must ride out a legal and regulatory storm
that could slow their deal, delay products and lead to costly court judgments
and government penalties. The companies face investigations, product-liability
lawsuits and warnings from the Food and Drug Administration to correct problems
at their manufacturing sites.
USA
Today
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May